June 08, 2020: "The U.S. Food and Drug Administration and the National Telecommunications and Information Administration (NTIA) are launching a 120-day pilot to help...
June 08, 2020, FibroGen, Inc. (NASDAQ: FGEN) today announced the initiation of an open-label, randomized, parallel-arm study investigating the efficacy and safety of pamrevlumab versus...
June 08, 2020 "Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced it has received U.S. Food and Drug...
JUN 8, 2020 AstraZeneca AZN approached Gilead Sciences GILD last month for a potential merger deal, Bloomberg reported on Sunday, citing people familiar with the matter.
The report mentioned...
June 08, 2020, OX2 Therapeutics, Inc, a privately held Minneapolis company, announced that ""it has received clearance from the U.S. Food and Drug Administration...
June 04, 2020: "U.S. Food and Drug Administration publicly posted test performance data from four more antibody, or serology, test kits on open.fda.gov from its independent...
June 04, 2020: "U.S. Food and Drug Administration approved Recarbrio (a combination of imipenem-cilastatin and relebactam) to treat hospital-acquired bacterial pneumonia and ventilator-associated...
June 04, 2020: "The U.S. Food and Drug Administration announced the following actions taken in its ongoing response effort to the COVID-19 pandemic:
Today, the...
June 03, 2020: The Lancet retracted the biggest study published regarding Hydroxychloroquine use for the treatment of COVID19.
"This study included all...
 June 04, 2020: "AbbVie, a research-based global biopharmaceutical company announced new long-term results showing that once daily upadacitinib continued to improve signs and symptoms...
June 4, 2020: "Novartis, a leader in rheumatology and immuno-dermatology announced the full 52-week results from the Phase III PREVENT trial, which reinforce the...